Literature DB >> 14726672

Fibronectin alters cell survival and intracellular signaling of confluent A549 cultures after irradiation.

N Cordes1, C Beinke.   

Abstract

Cell-cell and cell-extracellular matrix contacts influence cellular sensitivity to ionizing radiation. To further define the influence of these interactions on tumor cell survival and cell cycle progression after irradiation without or in combination with the phorbol ester phorbol-12-myristate-13-acetate (PMA), the radiation response of p53 wild-type A549 lung cancer cells grown on polystyrene, fibronectin (FN) or BSA was examined. Confluently growing and log-phase A549 cell cultures irradiated on FN showed significantly greater survival compared to cells irradiated on polystyrene or BSA. There was a significantly greater elevation of G(2)/M cells in FN cultures after irradiation compared to other culture conditions. PMA reduced radiation survival on all three substrata and under both log-phase and confluent culture conditions, but had no effect on the elevation of G(2)/M cells in FN cultures. Induction of Chk1 phosphorylation by irradiation was only seen in FN cultures. Chk2 and Cdk1 phosphorylation and Cdc25C expression also differed between FN and polystyrene cultures. Induction of p53 and p21 by irradiation was modulated but not inhibited by PMA, as were changes in cyclin D1 and pRb. Changes in protein expression and phosphorylation of these cell cycle regulatory proteins coincided tightly with accumulation of cells in G(2)/M after irradiation. These findings clearly demonstrate the influence of both intercellular and cell-substratum interactions on the radiation response without or in combination with PMA and differentiate between the cell survival and cell cycle effects of FN attachment.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14726672

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  8 in total

Review 1.  Integrin signalling and the cellular response to ionizing radiation.

Authors:  Nils Cordes; Viktor Meineke
Journal:  J Mol Histol       Date:  2004-03       Impact factor: 2.611

2.  Integrin-dependent amplification of the G2 arrest induced by ionizing radiation.

Authors:  Celeste L Kremer; Monika Schmelz; Anne E Cress
Journal:  Prostate       Date:  2006-01-01       Impact factor: 4.104

3.  RAD9 enhances radioresistance of human prostate cancer cells through regulation of ITGB1 protein levels.

Authors:  Constantinos G Broustas; Howard B Lieberman
Journal:  Prostate       Date:  2014-08-11       Impact factor: 4.104

Review 4.  Targeting the tumour stroma to increase efficacy of chemo- and radiotherapy.

Authors:  G Chometon; V Jendrossek
Journal:  Clin Transl Oncol       Date:  2009-02       Impact factor: 3.405

5.  Rapid and automated multidimensional fluorescence microscopy profiling of 3D human breast cultures.

Authors:  Catherine C Park; Walter Georgescu; Aris Polyzos; Christopher Pham; Kazi M Ahmed; Hui Zhang; Sylvain V Costes
Journal:  Integr Biol (Camb)       Date:  2013-02-13       Impact factor: 2.192

6.  Topical Fibronectin Improves Wound Healing of Irradiated Skin.

Authors:  Maxwell B Johnson; Brandon Pang; Daniel J Gardner; Solmaz Niknam-Benia; Vinaya Soundarajan; Athanasios Bramos; David P Perrault; Kian Banks; Gene K Lee; Regina Y Baker; Gene H Kim; Sunju Lee; Yang Chai; Mei Chen; Wei Li; Lawrence Kwong; Young-Kwon Hong; Alex K Wong
Journal:  Sci Rep       Date:  2017-06-20       Impact factor: 4.379

Review 7.  Prognostic value of increased integrin-beta 1 expression in solid cancers: a meta-analysis.

Authors:  Quanwu Sun; Chuan Zhou; Ruofei Ma; Qianhong Guo; Haiyun Huang; Jie Hao; Hong Liu; Rong Shi; Bo Liu
Journal:  Onco Targets Ther       Date:  2018-03-29       Impact factor: 4.147

8.  Irradiation differentially affects substratum-dependent survival, adhesion, and invasion of glioblastoma cell lines.

Authors:  N Cordes; B Hansmeier; C Beinke; V Meineke; D van Beuningen
Journal:  Br J Cancer       Date:  2003-12-01       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.